Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1558 studies found for:    "Squamous cell carcinoma"
Show Display Options
Rank Status Study
21 Completed Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Erlotinib;   Drug: Erlotinib plus sulindac;   Drug: Placebo
22 Completed Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma
Condition: SQUAMOUS CELL CARCINOMA
Intervention: Drug: celecoxib
23 Recruiting Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: Docetaxel;   Drug: Nedaplatin;   Radiation: chest radiation
24 Not yet recruiting Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Intervention: Device: No intervention, this is an observational study
25 Active, not recruiting Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma
Conditions: Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: vorinostat;   Drug: cisplatin;   Radiation: radiation therapy;   Procedure: Correlative Studies
26 Completed Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck
Condition: Squamous Cell Carcinoma
Intervention: Drug: Temsirolimus
27 Terminated Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas
Condition: Squamous Cell Carcinoma
Intervention: Drug: Selinexor (KPT-330)
28 Terminated Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma
Interventions: Drug: Azacitidine;   Drug: Cisplatin
29 Completed Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Chemotherapy;   Drug: Nimotuzumab and Chemotherapy
30 Recruiting Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma
Condition: Penile Squamous Cell Carcinoma (PSCC)
Intervention: Drug: Gilotrif
31 Not yet recruiting Study of the Efficacy of Single Agent BGJ398 in FGFR1-3 Translocated, Mutated, or Amplified Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Drug: BGJ398
32 Active, not recruiting Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"
Condition: Squamous Cell Carcinoma
Intervention: Other: SCC metastasis
33 Completed Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Biological: the arachidonic acid and EGFR signaling pathways and their interaction in HNSCC tumorigenesis,
34 Completed New Strategies Against Cutaneous Squamous Cell Carcinoma
Condition: Cutaneous Squamous Cell Carcinoma
Intervention: Radiation: Samples with 2 treatments
35 Completed Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel;   Drug: Methotrexate
36 Terminated Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: docetaxel+CDDP;   Drug: docetaxel+S-1
37 Completed Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma
Condition: Cutaneous Squamous Cell Carcinoma
Intervention:
38 Recruiting Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma
Condition: Lung Squamous Cell Carcinoma
Interventions: Genetic: CAR-GPC3 T Cells;   Drug: Fludarabine;   Drug: Cyclophosphamide
39 Recruiting Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: cisplatin;   Drug: carboplatin;   Drug: 5-FU
40 Terminated Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)
Condition: High Risk Cutaneous Squamous Cell Carcinoma
Intervention: Procedure: elective lymph node dissection

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.